Metabolic adaptation has been reported to promote cancer, yet the underlying mechanisms are not clear. Here, the authors show that m1A methylation in tRNA regulates cholesterol metabolism in liver cancer stem cells and m1A inhibition decreases tumourigenesis in preclinical models of hepatocellular carcinoma
SummaryDNA methylation in promoters is well known to silence genes and is the presumed therapeutic t...
Abstract N6-methyladenosine (m6A), the most prevalent modification of mammalian RNA, has received in...
S-adenosyl methionine (SAM) is a ubiquitous methyl donor that was reported to have chemo-protectiv...
The human cytoplasmatic pool of tRNA for the 20 proteinogenic amino acids and selenocysteine is comp...
Recently, covalent modifications of RNA, such as methylation, have emerged as key regulators of all ...
MicroRNAs (miR) are a class of small (∼21 nucleotide) noncoding RNAs that, in general, negatively re...
Methylation of lysine and arginine residues on histones has long been known to determine both chroma...
The tropomyosin-related kinase (Trk) family of neurotrophin receptors, TrkA, TrkB and TrkC, has been...
As cancer is a genetic disease, methylation defines a biologically malignant phenotype of cancer in ...
Liver cancer is the fifth most common malignant tumor in terms of incidence and the third leading ca...
Background and Aims: Genomic instability (GI) is involved in rodent and human hepatocellular carcin...
Comunicación presentada en New Horizons in Genomics symposium, celebrado en modalidad virtual del de...
Abstract As one of the most studied ribonucleic acid (RNA) modifications in eukaryotes, N6‐methylade...
Altered expression of microRNAs is frequently detected during tumor development; however, it has not...
Summary: Increased aerobic glycolysis is a hallmark of cancer metabolism. How cancer cells coordinat...
SummaryDNA methylation in promoters is well known to silence genes and is the presumed therapeutic t...
Abstract N6-methyladenosine (m6A), the most prevalent modification of mammalian RNA, has received in...
S-adenosyl methionine (SAM) is a ubiquitous methyl donor that was reported to have chemo-protectiv...
The human cytoplasmatic pool of tRNA for the 20 proteinogenic amino acids and selenocysteine is comp...
Recently, covalent modifications of RNA, such as methylation, have emerged as key regulators of all ...
MicroRNAs (miR) are a class of small (∼21 nucleotide) noncoding RNAs that, in general, negatively re...
Methylation of lysine and arginine residues on histones has long been known to determine both chroma...
The tropomyosin-related kinase (Trk) family of neurotrophin receptors, TrkA, TrkB and TrkC, has been...
As cancer is a genetic disease, methylation defines a biologically malignant phenotype of cancer in ...
Liver cancer is the fifth most common malignant tumor in terms of incidence and the third leading ca...
Background and Aims: Genomic instability (GI) is involved in rodent and human hepatocellular carcin...
Comunicación presentada en New Horizons in Genomics symposium, celebrado en modalidad virtual del de...
Abstract As one of the most studied ribonucleic acid (RNA) modifications in eukaryotes, N6‐methylade...
Altered expression of microRNAs is frequently detected during tumor development; however, it has not...
Summary: Increased aerobic glycolysis is a hallmark of cancer metabolism. How cancer cells coordinat...
SummaryDNA methylation in promoters is well known to silence genes and is the presumed therapeutic t...
Abstract N6-methyladenosine (m6A), the most prevalent modification of mammalian RNA, has received in...
S-adenosyl methionine (SAM) is a ubiquitous methyl donor that was reported to have chemo-protectiv...